Which dosing for medications in obese children?

被引:0
作者
Bardin, C. [1 ]
机构
[1] Hop Hotel Dieu, Serv Pharm Pharmacol Toxicol, F-75181 Paris 04, France
来源
ARCHIVES DE PEDIATRIE | 2009年 / 16卷 / 06期
关键词
PHARMACOKINETICS;
D O I
10.1016/S0929-693X(09)74220-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
[No abstract available]
引用
收藏
页码:965 / 967
页数:3
相关论文
共 10 条
  • [1] INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS
    BAUER, LA
    EDWARDS, WAD
    DELLINGER, EP
    SIMONOWITZ, DA
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) : 643 - 647
  • [2] Effects of obesity on pharmacokinetics - Implications for drug therapy
    Cheymol, G
    [J]. CLINICAL PHARMACOKINETICS, 2000, 39 (03) : 215 - 231
  • [3] Retrospective appraisal of busulfan dose adjustment in children
    Dupuis, LL
    Najdova, M
    Saunders, EF
    [J]. BONE MARROW TRANSPLANTATION, 2000, 26 (11) : 1143 - 1147
  • [4] Dosing of medications in morbidly obese patients in the intensive care unit setting
    Erstad, BL
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (01) : 18 - 32
  • [5] Impact of obesity on allogeneic stem cell transplant patients: A matched case-controlled study
    Fleming, DR
    Rayens, MK
    Garrison, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 1997, 102 (03) : 265 - 268
  • [6] What is the best size descriptor to use for pharmacokinetic studies in the obese?
    Green, B
    Duffull, SB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (02) : 119 - 133
  • [7] Mortality in overweight and children with acute myeloid underweight leukemia
    Lange, BJ
    Gerbing, RB
    Feusner, J
    Skolnik, J
    Sacks, N
    Smith, FO
    Alonzo, TA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (02): : 203 - 211
  • [8] Antimicrobial dosing considerations in obese adult patients - Insights from the society of infectious diseases pharmacists
    Pai, Manjunath P.
    Bearden, David T.
    [J]. PHARMACOTHERAPY, 2007, 27 (08): : 1081 - 1091
  • [9] Pharmacokinetics of doxorubicin and etoposide in a morbidly obese pediatric patient
    Ritzmo, Carina
    Soderhall, Stefan
    Karlen, Jonas
    Nygren, Helen
    Eksborg, Staffan
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2007, 24 (5-8) : 437 - 445
  • [10] Obesity in pediatric oncology
    Rogers, PC
    Meacham, LR
    Oeffinger, KC
    Henry, DW
    Lange, BJ
    [J]. PEDIATRIC BLOOD & CANCER, 2005, 45 (07) : 881 - 891